Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Serotonin transporter
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Ligands=== * [[DASB]] * compound 4b: ''K''i = 17 pM; 710-fold and 11,100-fold selective over DAT and NET<ref name="pmid15686927">{{cite journal | vauthors = Tamagnan G, Alagille D, Fu X, Kula NS, Baldessarini RJ, Innis RB, Baldwin RM | title = Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency | journal = Bioorganic & Medicinal Chemistry Letters | volume = 15 | issue = 4 | pages = 1131β1133 | date = February 2005 | pmid = 15686927 | doi = 10.1016/j.bmcl.2004.12.014 }}</ref> * compound (+)-12a: ''K''i = 180 pM at hSERT; >1000-fold selective over hDAT, hNET, 5-HT<sub>1A</sub>, and 5-HT<sub>6</sub>.<ref name="pmid16162005">{{cite journal | vauthors = Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ | title = Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors | journal = Journal of Medicinal Chemistry | volume = 48 | issue = 19 | pages = 6023β6034 | date = September 2005 | pmid = 16162005 | doi = 10.1021/jm0503291 }}</ref> [[Bioisostere|Isostere]]s<ref name="pmid17766113">{{cite journal | vauthors = Dalton King H, Denhart DJ, Deskus JA, Ditta JL, Epperson JR, Higgins MA, Kung JE, Marcin LR, Sloan CP, Mattson GK, Molski TF, Krause RG, Bertekap RL, Lodge NJ, Mattson RJ, Macor JE | title = Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor | journal = Bioorganic & Medicinal Chemistry Letters | volume = 17 | issue = 20 | pages = 5647β5651 | date = October 2007 | pmid = 17766113 | doi = 10.1016/j.bmcl.2007.07.083 }}</ref> * 3-''cis''-(3-Aminocyclopentyl)indole 8a: ''K''i = 220 pM<ref>{{cite journal | vauthors = King HD, Meng Z, Deskus JA, Sloan CP, Gao Q, Beno BR, Kozlowski ES, Lapaglia MA, Mattson GK, Molski TF, Taber MT, Lodge NJ, Mattson RJ, Macor JE | title = Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors | journal = Journal of Medicinal Chemistry | volume = 53 | issue = 21 | pages = 7564β7572 | date = November 2010 | pmid = 20949929 | doi = 10.1021/jm100515z }}</ref> * allosteric modulator: 3β²-Methoxy-8-methyl-spiro{8-azabicyclo[3.2.1]octane-3,5β²(4β²H)-isoxazole} (compound 7a)<ref>{{cite journal | vauthors = Dallanoce C, Canovi M, Matera C, Mennini T, De Amici M, Gobbi M, De Micheli C | title = A novel spirocyclic tropanyl-ΞΒ²-isoxazoline derivative enhances citalopram and paroxetine binding to serotonin transporters as well as serotonin uptake | journal = Bioorganic & Medicinal Chemistry | volume = 20 | issue = 21 | pages = 6344β6355 | date = November 2012 | pmid = 23022052 | doi = 10.1016/j.bmc.2012.09.004 }}</ref> * allosteric modulator: ''p''-Trifluoromethyl-[[methcathinone]]<ref name="pmid31028773">{{cite journal | vauthors = Niello M, Cintulova D, Hellsberg E, JΓ€ntsch K, Holy M, Ayatollahi LH, Cozzi NV, Freissmuth M, Sandtner W, Ecker GF, Mihovilovic MD, Sitte HH | title = para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter | journal = Neuropharmacology | volume = 161 | pages = 107615 | date = December 2019 | pmid = 31028773 | doi = 10.1016/j.neuropharm.2019.04.021 | s2cid = 128363044 | doi-access = }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)